TABLE 1.
IFO |
d4IFO |
|||||
---|---|---|---|---|---|---|
Vmaxa | Kma | Vmax/Km | Vmaxa | Kma | Vmax/Km | |
pmol/min/pmol P450 | mM | min–1mM–1 | pmol/min/pmol P450 | mM | min–1mM−1 | |
Activation | ||||||
CYP2B6 | 3.8 ± 1 | 4.6 ± 2 | 0.8 | 4.1 ± 0.4 | 2.0 ± 0.4 | 2 |
CYP2C9 | Trace amounts of acrolein formed | 0 | Trace amounts of acrolein formed | 0 | ||
CYP2C19 | 1.0 ± 0.2 | 1.1 ± 0.6 | 0.9 | 1.0 ± 0.1 | 1.2 ± 0.4 | 0.8 |
CYP3A4 | 0.7 ± 0.1 | 1.6 ± 0.6 | 0.4 | 0.4 ± 0.03 | 0.6 ± 0.12 | 0.7 |
CYP3A5 | 0.1 ± 0.01 | 0.04 ± 0.03 | 2.5 | Not tested | N/A | |
Inactivation | ||||||
CYP2B6 | 0.4 ± 0.04 | 2.0 ± 0.4 | 0.2 | 0.2 ± 0.05 | 2.0 ± 0.8 | 0.1 |
CYP2C9 | Trace amounts of CAA formed | 0 | Trace amounts of CAA formed | 0 | ||
CYP2C19 | No CAA formed | 0 | No CAA formed | 0 | ||
CYP3A4 | 0.14 ± 0.03 | 3.5 ± 1.7 | 0.04 | 0.05 ± 0.02 | 1.7 ± 1.2 | 0.03 |
CYP3A5 | 0.02 ± 0.005 | 0.4 ± 0.3 | 0.05 | Not tested | N/A |
Mean ± S.E.M.
N/A, CYP3A5 was not assessed for d4IFO metabolism.